Previous studies have revealed changes of adenosine A2A receptor expression in discrete brain regions of patients dying with Parkinson's disease as well as Parkinson's animal models (Hurley et al., 2000; Villar-Menendez et al., 2014). Here, ADORA2A is linked to Parkinson disease.